Status:
UNKNOWN
Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study
Lead Sponsor:
Poitiers University Hospital
Conditions:
Pancreatic Adenocarcinoma
Eligibility:
All Genders
18-100 years
Brief Summary
Little is known concerning the management of portal vein thrombosis (PVT) in digestive cancers other than hepato-cellular carcinoma (HCC). The use of anticoagulant treatment (ACT), screening of oesoph...
Eligibility Criteria
Inclusion
- Pancreatic adenocarcinoma proven histologically or cytologically in favor of pancreatic adenocarcinoma
- Mesurable disease according to RECIST 1.1 criteria or non measurable disease
- Metastatic disease (synchronous or metachronous) or locally advanced / borderline deemed unresectable and / or patient inoperable due to his co-morbidities and / or local recurrence after surgery
- Thrombosis of the main portal vein and/or of one of its branches (endo-luminal defect on the injected CTscan) of cruoric or tumoral origin or circumferential stenosis of the portal vein trunk, the spleno-mesaraic confluence or one of its venous branches with or without signs of portal hypertension on CTscan and / or upper GIendoscopy
Exclusion
- \- Post-surgical portal vein thrombosis and / or in patients considered in remission
- Non-adenocarcinomatous pancreatic tumor (endocrine, etc.)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04814251
Start Date
March 1 2021
End Date
December 1 2024
Last Update
March 24 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.